The moderna application clearly distinguishes between Covid-19 (symptomatic disease) and SARS-CoV-2 infection, as the sibling comment says. > On November 30, 2

The moderna application clearly distinguishes between Covid-19 (symptomatic disease) and SARS-CoV-2 infection, as the sibling comment says. > On November 30, 2020, ModernaTX (the Sponsor, also referred to as Moderna) submitted an Emergency Use Authorization (EUA) request to FDA for an investigational COVID-19 vaccine (mRNA-1273) intended to prevent COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). https://www.fda.gov/media/144673/download https://www.fda.gov/media/144673/download